Kingsview Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $558K | Sell |
5,193
-1,542
| -23% | -$166K | 0.01% | 737 |
|
|
2025
Q1 | $679K | Buy |
6,735
+172
| +3% | +$17.4K | 0.01% | 635 |
|
|
2024
Q4 | $586K | Buy |
6,563
+593
| +10% | +$53K | 0.01% | 692 |
|
|
2024
Q3 | $500K | Buy |
5,970
+282
| +5% | +$23.6K | 0.01% | 724 |
|
|
2024
Q2 | $438K | Buy |
5,688
+118
| +2% | +$9.09K | 0.01% | 726 |
|
|
2024
Q1 | $381K | Buy |
5,570
+219
| +4% | +$15K | 0.01% | 738 |
|
|
2023
Q4 | $309K | Sell |
5,351
-4,415
| -45% | -$255K | 0.01% | 757 |
|
|
2023
Q3 | $516K | Sell |
9,766
-168
| -2% | -$8.87K | 0.02% | 612 |
|
|
2023
Q2 | $537K | Buy |
9,934
+361
| +4% | +$19.5K | 0.02% | 568 |
|
|
2023
Q1 | $479K | Buy |
9,573
+3,799
| +66% | +$190K | 0.02% | 586 |
|
|
2022
Q4 | $267K | Buy |
5,774
+167
| +3% | +$7.73K | 0.01% | 701 |
|
|
2022
Q3 | $217K | Buy |
5,607
+175
| +3% | +$6.77K | 0.01% | 734 |
|
|
2022
Q2 | $202K | Sell |
5,432
-2,040
| -27% | -$75.9K | 0.01% | 763 |
|
|
2022
Q1 | $331K | Sell |
7,472
-3,600
| -33% | -$159K | 0.01% | 667 |
|
|
2021
Q4 | $470K | Hold |
11,072
| – | – | 0.02% | 585 |
|
|
2021
Q3 | $480K | Buy |
11,072
+1,400
| +14% | +$60.7K | 0.02% | 557 |
|
|
2021
Q2 | $419K | Buy |
+9,672
| New | +$419K | 0.02% | 608 |
|